Remove Diabetes Remove Vaccines Remove Webinar
article thumbnail

An introduction to the new NIHR National Patient Recruitment Centres

pharmaphorum

In a recent pharmaphorum webinar leaders from the NIHR’s five National Patient Recruitment Centres (NPRCs) outlined how they could bring cutting-edge therapies to greater numbers of UK patients. These include the delivery of COVID-19 vaccine trials and one of the UK’s first fully virtual interventional commercial clinical trials.

article thumbnail

Cell culture Q&A: Solving biomanufacturing challenges with Recombinant Insulin supplementation

Pharmaceutical Technology

This breakthrough led to a recombinant (biosynthetic) and thereby safer therapy for diabetes than the animal-sourced insulin which had been used since 1922. Insulin injections are still the chief way of managing Type 1 diabetes today; however, since then, the impact of Recombinant Insulin’s discovery has gone even further.

article thumbnail

Conducting successful commercial research in a primary care setting

pharmaphorum

This was the subject of a recent pharmaphorum webinar , developed in association with the National Institute of Health and Care Research (NIHR) where a panel of industry experts gathered to discuss how to unlock the promise of primary care sites in commercial research.